High-Throughput, High-Quality: Benchmarking GNINA and AutoDock Vina for Precision Virtual Screening Workflow
Molecules · 13.08.2025 · 30 (16) · 3361
DOI: 10.3390/molecules30163361 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 13.08.2025. Verfasst von Rocco Buccheri und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug and Health Sciences, University of Catania, Viale A. Doria 6, 95125 Catania, Italy. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Drug Discovery, Software, High-Throughput Screening Assays. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health, Piano di Sviluppo e Coesione del Ministero della Salute 2014-2020, Project: Pharma-HUB-Hub per il riposizionamento di farmaci nelle…, Italian Ministry of Health, National Centre for HPC, Big Data and Quantum Computing.
Abstract (Originalsprache)
Drug discovery is an intricate and resource-intensive process in which computational approaches, such as molecular docking, are essential, particularly in the early stages, to identify potential hits. However, docking still has many drawbacks, including problems in managing protein flexibility and the reliability of scoring functions. In this paper, we systematically compared the performance of AutoDock Vina, one of the most widely used open-source docking tools, with GNINA. This advanced evolution integrates convolutional neural networks (CNNs) for pose scoring. The comparison was conducted on ten heterogeneous protein targets, including metalloenzymes, kinases, and G-protein-coupled receptors (GPCRs). With the ability to accurately replicate binding poses and their energy values, GNINA showed outstanding performance in both virtual screening (VS) of active ligands and re-docking steps of co-crystallized ligands. GNINA’s enhanced ability to accurately distinguish between true positives and false positives—a specificity not found with AutoDock Vina—is confirmed by ROC curves and Enrichment Factor (EF) results. Therefore, we propose an integrated GNINA-based workflow that can significantly enhance the quality and reliability of docking results, providing a valuable tool for optimizing the initial stages of drug discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Drug and Health Sciences, University of Catania, Viale A. Doria 6, 95125 Catania, Italy.
ORCID-Profile: Rocco Buccheri, Antonio Rescifina
Förderung
- Italian Ministry of Health, Piano di Sviluppo e Coesione del Ministero della Salute 2014-2020, Project: Pharma-HUB-Hub per il riposizionamento di farmaci nelle…
- Italian Ministry of Health
- National Centre for HPC, Big Data and Quantum Computing
Zitieren
APA
Buccheri, R., & Rescifina, A. (2025). High-Throughput, High-Quality: Benchmarking GNINA and AutoDock Vina for Precision Virtual Screening Workflow. Molecules, 30(16), 3361. https://doi.org/10.3390/molecules30163361
Vancouver
Buccheri R, Rescifina A. High-Throughput, High-Quality: Benchmarking GNINA and AutoDock Vina for Precision Virtual Screening Workflow. Molecules. 2025;30(16):3361. doi:10.3390/molecules30163361
BibTeX
@article{Buccheri2025,
author = {Buccheri, Rocco and Rescifina, Antonio},
title = {High-Throughput, High-Quality: Benchmarking GNINA and AutoDock Vina for Precision Virtual Screening Workflow},
journal = {Molecules},
year = {2025},
volume = {30},
number = {16},
pages = {3361},
doi = {10.3390/molecules30163361}
}
EUVIMED